Literature DB >> 19398230

Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN.

Manlio Vinciguerra1, Fabio Carrozzino, Marion Peyrou, Sebastiano Carlone, Roberto Montesano, Roberto Benelli, Michelangelo Foti.   

Abstract

BACKGROUND/AIMS: The impact of dietary fatty acids on the development of cancers is highly controversial. We recently demonstrated that unsaturated fatty acids trigger the downregulation of the tumor suppressor PTEN through an mTOR/NF-kappaB-dependent mechanism in hepatocytes. In this study, we investigated whether unsaturated fatty acids promote hepatoma progression by downregulating PTEN expression.
METHODS: The effects of fatty acids and PTEN-specific siRNAs on proliferation, invasiveness and gene expression were assessed using HepG2 hepatoma cells. The tumor promoting activity of unsaturated fatty acids was evaluated in vivo using HepG2 xenografts in nude mice.
RESULTS: Incubation of HepG2 cells with unsaturated fatty acids, or PTEN-specific siRNAs, increased cell proliferation, cell migration and invasiveness, and altered the expression of genes involved in inflammation, epithelial-to-mesenchymal transition and carcinogenesis. These effects were dependent on PTEN expression levels and were prevented by mTOR and NF-kappaB inhibitors. Consistent with these data, the development and size of subcutaneous HepG2-derived tumors in nude mice xenografts were dramatically increased when mice were fed with an oleic acid-enriched diet, even in the absence of weight gain.
CONCLUSIONS: These data demonstrate that dietary unsaturated fatty acids promote hepatoma progression by reducing the expression of the tumor suppressor PTEN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19398230     DOI: 10.1016/j.jhep.2009.01.027

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  43 in total

1.  PTEN in liver diseases and cancer.

Authors:  Marion Peyrou; Lucie Bourgoin; Michelangelo Foti
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

2.  The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis.

Authors:  Stephan Laggai; Sonja M Kessler; Stefan Boettcher; Valérie Lebrun; Katja Gemperlein; Eva Lederer; Isabelle A Leclercq; Rolf Mueller; Rolf W Hartmann; Johannes Haybaeck; Alexandra K Kiemer
Journal:  J Lipid Res       Date:  2014-04-22       Impact factor: 5.922

Review 3.  Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.

Authors:  Paola Dongiovanni; Stefano Romeo; Luca Valenti
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Nonalcoholic fatty liver disease and hepatocellular carcinoma: new insights on presentation and natural history.

Authors:  Danny Issa; Naim Alkhouri
Journal:  Hepatobiliary Surg Nutr       Date:  2017-12       Impact factor: 7.293

5.  PATHOGENESIS OF HEPATOCELLULAR CARCINOMA DEVELOPMENT IN NON ALCOHOLIC FATTY LIVER DISEASE.

Authors:  Kirti Shetty; Jian Chen; Ji-Hyun Shin; Wilma Jogunoori; Lopa Mishra
Journal:  Curr Hepatol Rep       Date:  2015-06

6.  Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype.

Authors:  Elisabeth Tybl; Fu-Dong Shi; Sonja M Kessler; Sascha Tierling; Jörn Walter; Rainer M Bohle; Stefan Wieland; Jianying Zhang; Eng M Tan; Alexandra K Kiemer
Journal:  J Hepatol       Date:  2010-10-26       Impact factor: 25.083

7.  Overexpression of variant PNPLA3 gene at I148M position causes malignant transformation of hepatocytes via IL-6-JAK2/STAT3 pathway in low dose free fatty acid exposure: a laboratory investigation in vitro and in vivo.

Authors:  Zhengtao Liu; Tianchi Chen; Xiaoxiao Lu; Haiyang Xie; Lin Zhou; Shusen Zheng
Journal:  Am J Transl Res       Date:  2016-03-15       Impact factor: 4.060

8.  Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer Progression.

Authors:  Brandon T Sawyer; Lubna Qamar; Tomomi M Yamamoto; Alexandra McMellen; Zachary L Watson; Jennifer K Richer; Kian Behbakht; Isabel R Schlaepfer; Benjamin G Bitler
Journal:  Mol Cancer Res       Date:  2020-03-20       Impact factor: 5.852

Review 9.  NAFLD, NASH and liver cancer.

Authors:  Gregory A Michelotti; Mariana V Machado; Anna Mae Diehl
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-10-01       Impact factor: 46.802

10.  Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells.

Authors:  Oriana Lo Re; Julien Douet; Marcus Buschbeck; Caterina Fusilli; Valerio Pazienza; Concetta Panebianco; Carlo Castruccio Castracani; Tommaso Mazza; Giovanni Li Volti; Manlio Vinciguerra
Journal:  Epigenetics       Date:  2018-09-29       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.